Clinical Trials Logo

Clinical Trial Summary

Context: Approximately 100 million people throughout the world consume water contaminated with arsenic at levels above carcinogenic thresholds, including 40 million in Bangladesh alone, with up to one-fourth of deaths attributed to arsenic exposure in the worst-affected regions. There are no proven therapies for treating chronic arsenic toxicity or for preventing arsenical cancers. Selenium has been known to counter arsenic toxicity in a variety of animal models. The investigators have recently shown in animals and humans that this effect is mediated by the formation of [(GS)2AsSe]- , the seleno-bis(S-glutathionyl) arsinium ion, which is then rapidly excreted via the hepatobiliary system. Concurrently, two Phase II studies in China and Bangladesh have suggested clinical benefit to selenium supplementation in arsenicosis patients.

Objective: To assess whether daily selenium supplementation counters arsenic toxicity in patients exposed to drinking water arsenic. If proven effective, selenium supplementation might be safely and cost-effectively implemented in the worst-affected localities.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01442727
Study type Interventional
Source Texas Tech University
Contact
Status Completed
Phase Phase 3
Start date December 2006
Completion date April 2009

See also
  Status Clinical Trial Phase
Completed NCT03127670 - Effect of Solanum Melongena Extract in the Treatment of Arsenical Skin Lesion Phase 2
Completed NCT01735097 - Effect of Nigella Sativa in the Treatment of Palmer Arsenical Keratosis N/A
Completed NCT01731756 - Effects of Leaf Extract of Azadirachta Indica in Palmer Arsenical Keratosis N/A
Completed NCT01752972 - Effect of Spirulina on Zinc, Vitamin E and Linoleic Acid Levels in Palm Skin Following Chronic Exposure to Arsenic N/A